FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284697965> ?p ?o ?g. }

• W4284697965 endingPage "3285" @default.
• W4284697965 startingPage "3285" @default.
• W4284697965 abstract "(1) Background: SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare sinonasal malignancy; since its discovery and description in 2014, less than 200 cases have been identified. It is almost impossible to perform randomized-controlled trials on novel therapy to improve treatment outcomes in view of its rarity. We performed a systematic review of all the published case reports/series and included our patients for survival analysis. (2) Methods: In this systematic review, we searched from PubMed-MEDLINE, EMBASE, Scopus, Cochrane Library, CINAHL, and Google Scholar for individual patient data to identify and retrieve all reported SMARCB1-deficient sinonasal carcinoma. Clarification on treatment details and the most updated survival outcomes from all authors of the published case reports/series were attempted. Survival analysis for overall survival (OS) and identification of OS prognostic factors were performed. This systematic review was registered with PROSPERO (CRD42022306671). (3) Results: A total of 67 publications were identified from the systematic review and literature search. After excluding other ineligible and duplicated publications, 192 patients reported were considered appropriate for further review. After excluding duplicates and patients with incomplete pretreatment details and survival outcomes, 120 patients were identified to have a complete set of data including baseline demographics, treatment details, and survival outcomes. Together with 8 patients treated in our institution, 128 patients were included into survival analysis. After a median follow up of 17.5 months (range 0.3-149.0), 50 (46.3%) patients died. The 1-year, 2-year and 3-year OS rates were 84.3% (95% CI % 77.6-91.0), 62.9% (95% CI 53.1-72.7), and 51.8% (95% CI 40.8-62.8), respectively, and the median OS was 39.0 months (95% CI 28.5-49.5). Males (p = 0.029) and T4b disease (p = 0.013) were significant OS prognostic factors in univariable analysis, while only T4b disease (p = 0.017) remained significant in multivariable analysis. (4) Conclusions: SMARCB1-deficient sinonasal carcinoma is an extremely aggressive sinonasal malignancy with a dismal prognosis. Early diagnosis and a multimodality treatment strategy are essential for a better treatment and survival outcome." @default.
• W4284697965 created "2022-07-08" @default.
• W4284697965 creator A5008092548 @default.
• W4284697965 creator A5015827883 @default.
• W4284697965 creator A5018040982 @default.
• W4284697965 creator A5024313900 @default.
• W4284697965 creator A5064438645 @default.
• W4284697965 creator A5070808098 @default.
• W4284697965 creator A5080743533 @default.
• W4284697965 creator A5086759252 @default.
• W4284697965 date "2022-07-05" @default.
• W4284697965 modified "2023-10-18" @default.
• W4284697965 title "SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes" @default.
• W4284697965 cites W1687408895 @default.
• W4284697965 cites W1969512342 @default.
• W4284697965 cites W2048832587 @default.
• W4284697965 cites W2055479802 @default.
• W4284697965 cites W2059058989 @default.
• W4284697965 cites W2068077839 @default.
• W4284697965 cites W2072235933 @default.
• W4284697965 cites W2092741167 @default.
• W4284697965 cites W2096495102 @default.
• W4284697965 cites W2110043692 @default.
• W4284697965 cites W2132310381 @default.
• W4284697965 cites W2143008582 @default.
• W4284697965 cites W2253888479 @default.
• W4284697965 cites W2346005456 @default.
• W4284697965 cites W2399754071 @default.
• W4284697965 cites W2468901959 @default.
• W4284697965 cites W2511279395 @default.
• W4284697965 cites W2522401034 @default.
• W4284697965 cites W2529593410 @default.
• W4284697965 cites W2539184391 @default.
• W4284697965 cites W2561423497 @default.
• W4284697965 cites W2613321519 @default.
• W4284697965 cites W2616150682 @default.
• W4284697965 cites W2765105874 @default.
• W4284697965 cites W2770702567 @default.
• W4284697965 cites W2784056072 @default.
• W4284697965 cites W2797292560 @default.
• W4284697965 cites W2803881364 @default.
• W4284697965 cites W2887861237 @default.
• W4284697965 cites W2907165378 @default.
• W4284697965 cites W2922438242 @default.
• W4284697965 cites W2942904341 @default.
• W4284697965 cites W2947683272 @default.
• W4284697965 cites W2952311237 @default.
• W4284697965 cites W2957399827 @default.
• W4284697965 cites W2963847158 @default.
• W4284697965 cites W2969644320 @default.
• W4284697965 cites W2971075770 @default.
• W4284697965 cites W2986633517 @default.
• W4284697965 cites W3001655813 @default.
• W4284697965 cites W3019577809 @default.
• W4284697965 cites W3025934168 @default.
• W4284697965 cites W3032616285 @default.
• W4284697965 cites W3043362770 @default.
• W4284697965 cites W3066072899 @default.
• W4284697965 cites W3087076946 @default.
• W4284697965 cites W3088597672 @default.
• W4284697965 cites W3092409743 @default.
• W4284697965 cites W3092484545 @default.
• W4284697965 cites W3096298937 @default.
• W4284697965 cites W3129450953 @default.
• W4284697965 cites W3143743575 @default.
• W4284697965 cites W3157510000 @default.
• W4284697965 cites W3180572232 @default.
• W4284697965 cites W3195887040 @default.
• W4284697965 cites W3202804314 @default.
• W4284697965 cites W3204902679 @default.
• W4284697965 cites W4210278328 @default.
• W4284697965 doi "https://doi.org/10.3390/cancers14133285" @default.
• W4284697965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35805058" @default.
• W4284697965 hasPublicationYear "2022" @default.
• W4284697965 type Work @default.
• W4284697965 citedByCount "8" @default.
• W4284697965 countsByYear W42846979652022 @default.
• W4284697965 countsByYear W42846979652023 @default.
• W4284697965 crossrefType "journal-article" @default.
• W4284697965 hasAuthorship W4284697965A5008092548 @default.
• W4284697965 hasAuthorship W4284697965A5015827883 @default.
• W4284697965 hasAuthorship W4284697965A5018040982 @default.
• W4284697965 hasAuthorship W4284697965A5024313900 @default.
• W4284697965 hasAuthorship W4284697965A5064438645 @default.
• W4284697965 hasAuthorship W4284697965A5070808098 @default.
• W4284697965 hasAuthorship W4284697965A5080743533 @default.
• W4284697965 hasAuthorship W4284697965A5086759252 @default.
• W4284697965 hasBestOaLocation W42846979651 @default.
• W4284697965 hasConcept C118552586 @default.
• W4284697965 hasConcept C126322002 @default.
• W4284697965 hasConcept C143998085 @default.
• W4284697965 hasConcept C168563851 @default.
• W4284697965 hasConcept C17744445 @default.
• W4284697965 hasConcept C189708586 @default.
• W4284697965 hasConcept C199539241 @default.
• W4284697965 hasConcept C27415008 @default.
• W4284697965 hasConcept C2776478404 @default.
• W4284697965 hasConcept C2779399171 @default.

• next